Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice

References

• Alberts, D. S., Liu, P. Y., Hanningan, E. V., et al. (1996). Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. NEJM 335:1950–1955.
   PubMed Web of Science ®Google Scholar
• Bangham, A. D., Standish, M. M., Watkins, J. C. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238–252.
   PubMed Web of Science ®Google Scholar
• Bayomi, M. A., Al-Angary, A. A., Al-Meshal, M. A., Al-Dardiri, M. M. (1998). In vivo evaluation of arteether liposomes. Int J Pharm 175:1–7.
   Web of Science ®Google Scholar
• Bilia, A. R., Melillo de Malghldhaes, P., Bergonzi, M. C., Vincieri, F. F. (2006). Simultaneous analysis of artemisinin and flavonoids of several extracts of Artemisia annua L. obtained from a commercial sample and a selected cultivar. Phytomedicine 13:487–493.
   PubMed Web of Science ®Google Scholar
• Bormann, S., Szlezak, N., Faucher, J. F., Matsiegui, P. B., Neubauer, R., Biner, R. K., et al. (2001). Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study. J Infect Dis 184:1363–1366.
   PubMedGoogle Scholar
• Chen, Y., Xianfu, L., Hyunjin, P., Greever, R. (2009). Study of artemisinin nanocapsules as anticancer drug delivery systems. Nanomedicine 5:316–322.
   PubMed Web of Science ®Google Scholar
• Chimanuka, B., Gabriels, M., Detaevernier, M. R., Plaizier-Vercammen, J. A. (2002). Preparation of β-artemether liposomes, their HPLC-UV evaluation, and relevance for clearing recrudescent parasitaemia in Plasmodium chabaudi malaria-infected mice. J Pharm Biomed Anal 28:13–22.
   PubMed Web of Science ®Google Scholar
• Duffy, P. E., Mutabingwa, T. K. (2004). Drug combinations for malaria: time to ACT? Lancet 363:3–4.
   PubMedGoogle Scholar
• Efferth, T., Dunstan, H., Sauerbrey, A., Miyachi, H., Chitambar, C. R. (2001). The anti-malarial, artesunate, is also active against cancer. Int J Oncol 18:767–773.
   PubMed Web of Science ®Google Scholar
• Gabriels, M., Plaizier-Vercammen J. (2003). Physical and chemical evaluation of liposomes, containing artesunate. J Pharm Biomed Anal 31:655–667.
   PubMed Web of Science ®Google Scholar
• Gibaldi, M., Perrier, D. (1982). Pharmacokinetics, 2nd ed. New York: Dekker.
   Google Scholar
• Heppner, D. G., Ballou, V. R. (1998). Malaria in 1998: advances in diagnosis, drugs, and vaccine development. Curr Opin Infect Dis 11:519–530.
   PubMedGoogle Scholar
• Kirby, C., Gregoriadis, G. (1983). The effect of lipid composition of small unilamellar liposomes containing melphalan and vincristine on drug clearance after injection into mice. Biochem Pharmacol 32:609–615.
   PubMed Web of Science ®Google Scholar
• Klaiman, D. L. (1985). Quinghaosu (artemisinin): an antimalarial drug from China. Science 228:1049–1055.
   PubMedGoogle Scholar
• Lai, H., Singh, N. P. (1995). Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett 91:41–46.
   PubMed Web of Science ®Google Scholar
• Lai, H., Singh, N. P. (2006). Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat. Cancer Lett 231:43–48.
   PubMed Web of Science ®Google Scholar
• Lian, T., Ho, R. J. Y. (2001). Trends and developments in liposome drug delivery systems. J Pharm Sci 90:667–680.
   PubMed Web of Science ®Google Scholar
• Lin, Y. Y., Li, J. J., Chang, C. H., Lu, Y. C., Hwang, J. J., Tseng, Y. L., et al. (2009). Evaluation of pharamacokinetics of 111In-labeled VNB-PEGylated liposomes after i.p. and i.v. administration in a tumor/ascites mouse model. Cancer Biother Radiopharm 24:453–460.
   PubMed Web of Science ®Google Scholar
• Liu, D., Huang, L. (1992). Size homogeneity of a liposome preparation is crucial for liposome biodistribution in vivo. Liposomes Res 2:57–66.
   Google Scholar
• Meshnick, S. R. (1998). Artemisinin antimalarials mechanism of action and resistance. Med Trop 58:13–17.
   PubMedGoogle Scholar
• Meyer, H. W., Bunjes, H., Ulrich, A. S. (1999). Morphological transitions of brain sphingomyelin are determined by the hydration protocol: ripples re-arrange in plane, and sponge-like networks distintegrate into small vesicles. Chem Phys Lipids 99:111–123.
   PubMedGoogle Scholar
• Meyer, H. W., et al. (1998). Minimal radius of curvature of lipid bilayers in the gel phase state correspond to the dimension of biomembrane structures “caveolae”. J Struct Biol 124:77–87.
   PubMedGoogle Scholar
• Meyer, H. W., et al. (2000). Hydration of DMPC and DPPC at 4 degrees C produces a novel subgel phase with convex-concave bilayer curvatures. Chem Phys Lipids 105:149–166.
   PubMed Web of Science ®Google Scholar
• Meyer, H. W., Richter, W. (2001). Freeze-fracture studies on lipids and membranes. Micron 32:615–644.
   PubMedGoogle Scholar
• Oussoren, C., Zuidema, J., Crommelin, D. J. A., Storm, G.. (1997). Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid composition, and lipid dose. Biochim Biophys Acta 1328:261–272.
   Google Scholar
• Parker, R. J., Hartman, K. D., Sieber, S. M. (1981a). Lymphatic absorption and tissue disposition of liposome-entrapped [14C] adriamycin following intraperitoneal administration to rats. Cancer Res 41:1311–1317.
   PubMed Web of Science ®Google Scholar
• Parker, R. J., Priester, E., Sieber, S. M. (1981b). Comparison of lymphatic uptake, metabolism, excretion, and biodistribution of free and liposome-entrapped [14C] cytosine b-D-arabinofuranoside following intraperitoneal administration to rats. Drug Metab Dispos 10:40–46.
   Google Scholar
• Phillips, W. T., Andrews, T., Liu, H., Klipper, R., Landry, A. J., Jr., Blumhardt, R., et al. (2001). Evaluation of [99mTc] liposomes as lymphoscintigraphic agents: comparison with [99mTc] sulfur colloid and [99mTc] human serum albumin. Nucl Med Biol 28:435–444.
   PubMed Web of Science ®Google Scholar
• Qinghaosu Antimalaria Coordinating Research Group. (1979). Antimalarial studies on qinghaosu. Chin Med J 92:811–816.
   PubMed Web of Science ®Google Scholar
• Romero, M. R., Efferth, T., Serrano, M. A., Castano, B., Macias, R. I., Briz, O., et al. (2005). Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an in vitro system. Antivir Res 68:75–83.
   PubMed Web of Science ®Google Scholar
• Sadzuka, Y., Hirota, S., Sonobe, T. (2000). Intraperitoneal administration of doxorubicin encapsulating liposomes against peritoneal dissemination. Toxicol Lett 116:51–56.
   PubMed Web of Science ®Google Scholar
• Sadzuka, Y., Nakai, S., Miyagishima, A., et al. (1997). Effects of administered route on tissue distribution and antitumor activity of PEG-coated liposomes containing adriamycin. Cancer Lett 111:77–86.
   PubMed Web of Science ®Google Scholar
• Singh, N. P., Lai, H. (2001). Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci 70:49–56.
   PubMed Web of Science ®Google Scholar
• Singh, N. P., Lai, H. (2004). Artemisinin induces apoptosis in human cancer cells. Anticancer Res 24:2277–2280.
   PubMed Web of Science ®Google Scholar
• Titulaer, H. A. C., Zuidema, J., Lugt, C. B. (1991). Formulation and pharmacokinetics of artemisinin and its derivatives. Int J Pharm 69:83–92.
   Web of Science ®Google Scholar
• Ulrich, A. S., et al. (1999). Ultrastructural characterization of peptide-induce membrane fusion and peptide self-assembly in the lipid bilayer. Biophys J 77:829–841.
   PubMedGoogle Scholar
• Utzinger, J., Xiao, S., N’Goran, E. K., Berquist, R., Tanner, M. (2001). The potential of artemether for the control of schistosomiasis. Int J Parasitol 31:1549–1562.
   PubMed Web of Science ®Google Scholar
• van Agtmael, M. A., Eggelte, T. A., van Boxtel, C. J. (1999). Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. Trends Pharmacol Sci 20:199–205.
   PubMed Web of Science ®Google Scholar
• Wong, J. W., Yuen, K. H. (2003). Inclusion complexation of artemisinin with α-, β-, and γ-cyclodextrins. Drug Dev Ind Pharm 29:1035–1044.
   PubMed Web of Science ®Google Scholar
• Wong, J. W., Yuen, K. H. (2001). Improved oral bioavailability of artemisinin through inclusion complexation with β- and γ-cyclodextrins. Int J Pharm 227:177–185.
   PubMed Web of Science ®Google Scholar
• World Health Organization. (1994). The role of artemisinin and its derivatives in the current treatment of malaria (1994–1995). Report of an informal consultation convened by WHO in Gevena 27–29 September 1993 (p 94 mimeographed document WHO/MAL/.1067). Geneva, Switzerland: World Health Organization.
   Google Scholar